{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"7.860","rs_stock_flag":false,"fiscal_year_end":"31 Dec 2024","hist_closedate":"25 Sep 2025","replication_method":null,"amt_os":"1,467,157,068","primaryexch":"HKEX","ric":"2616.HK","product_subtype":null,"db_updatetime":"26 Sep 2025 18:38","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":0.0,"inline_upper_strike_price":"","sedol":"BHZ6573","am":"151.28","iv":"","ew_strike":"","as":"7.450","geographic_focus":null,"incorpin":"Cayman Islands","etp_baseCur":null,"ew_amt_os":"","bd":"7.420","registrar":"Computershare Hong Kong Investor Services Ltd.","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"500","update_time":"2025-09-26 10:38:37.0","lo52":"1.390","shares_issued_date":"31 Aug 2025","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":"Wei Li","underlying_ric":"2616.HK","hi52":"13.150","issuer_name":"CStone Pharmaceuticals - B","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"26 Sep 2025 16:08","aum_date":"","lo":"7.360","mkt_cap":"10.93","f_aum_hkd":null,"ew_sub_per_to":"","ls":"7.450","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"Healthcare - Pharmaceuticals & Biotechnology","ew_desc":null,"inception_date":"","nc":"-0.360","aum":"","issued_shares_class_B":null,"vo":"20.13","secondary_listing_flag":false,"listing_date":"26 Feb 2019","issued_shares_class_A":null,"as_at_label":"as at","ew_amt_os_dat":"","nm":"CStone Pharmaceuticals - B","nm_s":"CSTONE PHARMA-B","sym":"2616","inline_lower_strike_price":"","listing_category":"Primary Listing","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.010","strike_price":"","summary":"CStone Pharmaceuticals is a biopharmaceutical investment holding company focused on the research and development of anti-cancer therapies. Through its subsidiaries, the Company is primarily engaged in the research and development of biopharmaceutical products, sale of pharmaceutical products and provision of license of its intellectual property (IP) or commercialization license. The Companyâ€™s main products include targeted therapies, AYVAKIT (avapritinib) and GAVRETO (pralsetinib). The Company is also involved in the development and commercialization of immuno-oncology. The Company mainly conducts its businesses in the domestic market and overseas markets, such as Central and Eastern Europe and Switzerland.","op":"7.810","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"Biotechnology","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"40th Floor, Sunlight Tower<br/>No. 248 Queen's Road East<br/>Wanchai<br/>Hong Kong","pc":"-4.61","days_to_expiry":null,"underlying_code":null,"pe":"","eps_ccy":"RMB","hdr":false,"launch_date":"","hc":"7.810","isin":"KYG2588M1006","moneyness":""}},"qid":"1758890108763"}
